Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1986 1
1987 2
1991 2
1992 1
1993 2
1994 1
1995 1
1996 3
1997 3
1998 4
1999 8
2000 5
2001 3
2002 3
2003 2
2004 6
2005 5
2006 9
2007 5
2008 2
2009 8
2010 3
2011 6
2012 5
2013 3
2014 8
2015 4
2016 6
2017 5
2018 3
2019 7
2020 10
2021 9
2022 6
2023 8
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

145 results

Results by year

Filters applied: . Clear all
Page 1
Decitabine in Older Patients with AML: Quality of Life Results of the EORTC-GIMEMA-GMDS-SG Randomized Phase III Trial.
Efficace F, Kicinski M, Coens C, Suciu S, van der Velden WJFM, Noppeney R, Chantepie SP, Griskevicius L, Neubauer A, Audisio E, Luppi M, Fuhrmann S, Foà R, Crysandt M, Gaidano G, Vrhovac R, Venditti A, Posthuma EFM, Candoni A, Baron F, Legrand O, Mengarelli A, Fazi P, Vignetti M, Giraut A, Wijermans PW, Huls GA, Lübbert M. Efficace F, et al. Among authors: legrand o. Blood. 2024 May 8:blood.2023023625. doi: 10.1182/blood.2023023625. Online ahead of print. Blood. 2024. PMID: 38717861
10-day decitabine versus 3 + 7 chemotherapy followed by allografting in older patients with acute myeloid leukaemia: an open-label, randomised, controlled, phase 3 trial.
Lübbert M, Wijermans PW, Kicinski M, Chantepie S, Van der Velden WJFM, Noppeney R, Griškevičius L, Neubauer A, Crysandt M, Vrhovac R, Luppi M, Fuhrmann S, Audisio E, Candoni A, Legrand O, Foà R, Gaidano G, van Lammeren-Venema D, Posthuma EFM, Hoogendoorn M, Giraut A, Stevens-Kroef M, Jansen JH, de Graaf AO, Efficace F, Ammatuna E, Vilque JP, Wäsch R, Becker H, Blijlevens N, Dührsen U, Baron F, Suciu S, Amadori S, Venditti A, Huls G; EORTC Leukemia Group, GIMEMA, and German MDS Study Group. Lübbert M, et al. Among authors: legrand o. Lancet Haematol. 2023 Nov;10(11):e879-e889. doi: 10.1016/S2352-3026(23)00273-9. Lancet Haematol. 2023. PMID: 37914482 Free article. Clinical Trial.
Reduced post-transplant cyclophosphamide dose with antithymocyte globulin in peripheral blood stem cell haploidentical transplantation.
Duléry R, Malard F, Brissot E, Banet A, Sestili S, Belhocine R, Calabro M, Van de Wyngaert Z, Bonnin A, Ledraa T, Legrand O, Labopin M, Capderou E, Cohen A, Ederhy S, Mohty M. Duléry R, et al. Among authors: legrand o. Bone Marrow Transplant. 2023 Nov;58(11):1215-1222. doi: 10.1038/s41409-023-02085-2. Epub 2023 Aug 18. Bone Marrow Transplant. 2023. PMID: 37596473
Midostaurin plus daunorubicin or idarubicin for young and older adults with FLT3-mutated AML: a phase 3b trial.
Sierra J, Montesinos P, Thomas X, Griskevicius L, Cluzeau T, Caillot D, Legrand O, Minotti C, Luppi M, Farkas F, Bengoudifa BR, Gilotti G, Hodzic S, Rambaldi A, Venditti A. Sierra J, et al. Among authors: legrand o. Blood Adv. 2023 Nov 14;7(21):6441-6450. doi: 10.1182/bloodadvances.2023009847. Blood Adv. 2023. PMID: 37581981 Free PMC article. Clinical Trial.
Olutasidenib (FT-2102) induces durable complete remissions in patients with relapsed or refractory IDH1-mutated AML.
de Botton S, Fenaux P, Yee K, Récher C, Wei AH, Montesinos P, Taussig DC, Pigneux A, Braun T, Curti A, Grove C, Jonas BA, Khwaja A, Legrand O, Peterlin P, Arnan M, Blum W, Cilloni D, Hiwase DK, Jurcic JG, Krauter J, Thomas X, Watts JM, Yang J, Polyanskaya O, Brevard J, Sweeney J, Barrett E, Cortes J. de Botton S, et al. Among authors: legrand o. Blood Adv. 2023 Jul 11;7(13):3117-3127. doi: 10.1182/bloodadvances.2022009411. Blood Adv. 2023. PMID: 36724515 Free PMC article.
Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study.
Verstovsek S, Gerds AT, Vannucchi AM, Al-Ali HK, Lavie D, Kuykendall AT, Grosicki S, Iurlo A, Goh YT, Lazaroiu MC, Egyed M, Fox ML, McLornan D, Perkins A, Yoon SS, Gupta V, Kiladjian JJ, Granacher N, Lee SE, Ocroteala L, Passamonti F, Harrison CN, Klencke BJ, Ro S, Donahue R, Kawashima J, Mesa R; MOMENTUM Study Investigators. Verstovsek S, et al. Lancet. 2023 Jan 28;401(10373):269-280. doi: 10.1016/S0140-6736(22)02036-0. Lancet. 2023. PMID: 36709073 Clinical Trial.
Tixagevimab/cilgavimab for Omicron SARS-CoV-2 infection in patients with haematologic diseases.
Otiniano A, van de Wyngaert Z, Brissot E, Dulery R, Gozlan J, Daguenel A, Abi Aad Y, Ricard L, Stocker N, Banet A, Bonnin A, Alsuliman T, Marjanovic Z, Schnuriger A, Coppo P, Legrand O, Lacombe K, Mohty M, Malard F. Otiniano A, et al. Among authors: legrand o. Bone Marrow Transplant. 2023 Mar;58(3):340-342. doi: 10.1038/s41409-022-01894-1. Epub 2022 Dec 8. Bone Marrow Transplant. 2023. PMID: 36481838 Free PMC article. No abstract available.
Thiotepa, busulfan and fludarabine conditioning-regimen is a promising approach for older adult patients with acute lymphoblastic leukemia treated with allogeneic stem cell transplantation.
Banet A, Bazarbachi A, Labopin M, Stocker N, Duléry R, Malard F, Van de Wyngaert Z, Genthon A, Memoli M, Legrand O, Bonnin A, Ledraa T, Belhocine R, Sestili S, El-Cheikh J, Mohty M, Brissot E. Banet A, et al. Among authors: legrand o. Bone Marrow Transplant. 2023 Jan;58(1):61-67. doi: 10.1038/s41409-022-01841-0. Epub 2022 Oct 12. Bone Marrow Transplant. 2023. PMID: 36224494
Invasive Fungal Rhinosinusitis Due to Co-infection with Mucormycosis and Exserohilum rostratum in a Patient with Acute Lymphoblastic Leukemia.
Radici V, Brissot E, Chartier S, Guitard J, Fabiani B, Memoli M, Banet A, Heuberger L, Lapusan S, Atallah S, Legrand O, Genthon A. Radici V, et al. Among authors: legrand o. Clin Hematol Int. 2022 Jun 13;4(1-2):60-64. doi: 10.1007/s44228-022-00009-3. eCollection 2022 Jun. Clin Hematol Int. 2022. PMID: 35950207 Free PMC article.
Clinical and biological impact of ATP-binding cassette transporter activity in adult acute myeloid leukemia.
Sourdeau E, Suner L, Memoli M, Genthon A, Feger F, Soret L, Abermil N, Heuberger L, Bilhou-Nabera C, Guermouche H, Favale F, Lapusan S, Chaquin M, Hirschauer C, Mohty M, Legrand O, Delhommeau F, Hirsch P. Sourdeau E, et al. Among authors: legrand o. Haematologica. 2023 Jan 1;108(1):61-68. doi: 10.3324/haematol.2022.280676. Haematologica. 2023. PMID: 35924580 Free PMC article.
145 results